Ildirim I, Hacimustafaoğlu M, Ediz B
Department of Pediatrics, Uludağ University Faculty of Medicine, Görükle, Bursa, Turkey.
Pediatr Infect Dis J. 1995 Dec;14(12):1060-3. doi: 10.1097/00006454-199512000-00006.
In developing countries with a higher prevalence of tuberculous infection, usually more than one Bacillus Calmette-Guérin (BCG) vaccine is recommended. Revaccination can considerably alter the tuberculin skin test response and the diagnosis of tuberculous infection. In this study to assess the relationship between the number of BCG vaccinations and tuberculin skin reactions, 3548 children (ages 6 to 12 years) from 7 elementary schools were given 5 tuberculin units of purified protein derivative, and results were compared taking vaccination status into account. Forty-seven children were excluded from the study. Mean purified protein derivative induration size at 72 hours was 3.2 +/- 3.9 mm with no BCG scar (n = 1518), 6.3 +/- 7.8 mm with 1 scar (n = 1513), 10.7 +/- 6.2 mm with 2 scars (n = 433) and 14.8 +/- 4.3 mm with 3 scars (n = 37). In children with no scar the 90th percentile values of the size of the purified protein derivative induration were 10 mm. The 90th percentile values of children with one, two and three scars were 15, 17.5 and 20 mm, respectively. We suggest that tuberculin skin test responses be evaluated with regard to the number of previous BCG vaccinations.
在结核感染患病率较高的发展中国家,通常建议接种不止一剂卡介苗(BCG)。再次接种会显著改变结核菌素皮肤试验反应以及结核感染的诊断。在本研究中,为评估卡介苗接种次数与结核菌素皮肤反应之间的关系,对来自7所小学的3548名儿童(6至12岁)给予5结核菌素单位的纯化蛋白衍生物,并在考虑接种状况的情况下比较结果。47名儿童被排除在研究之外。无卡介苗疤痕的儿童(n = 1518)72小时时纯化蛋白衍生物硬结平均大小为3.2 +/- 3.9毫米,有1个疤痕的为6.3 +/- 7.8毫米(n = 1513),有2个疤痕的为10.7 +/- 6.2毫米(n = 433),有3个疤痕的为14.8 +/- 4.3毫米(n = 37)。无疤痕儿童纯化蛋白衍生物硬结大小的第90百分位数为10毫米。有1个、2个和3个疤痕的儿童第90百分位数分别为15、17.5和20毫米。我们建议根据既往卡介苗接种次数来评估结核菌素皮肤试验反应。